Back to top
more

Inogen (INGN)

(Delayed Data from NSDQ)

$9.62 USD

9.62
227,645

-0.08 (-0.83%)

Updated Oct 1, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 20% (50 out of 252)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Lantheus (LNTH) Scores a Strong Buy Right Now: Here's How

by Zacks Equity Research

Lantheus Holdings, Inc. (LNTH) has rallied 28.2% over the last three months, ahead of the S&P 500's 4.3% gain.

    Baxter (BAX) Scales 52-Week High: What's Behind the Rally

    by Zacks Equity Research

    Baxter International Inc. (BAX) scaled a new 52-week high of $60.47 on Jun 21, closing a bit lower at $60.05.

      GNC Holdings Continues to Gain from New GNC, Global Revenue

      by Zacks Equity Research

      On Jun 20 2017, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).

        PerkinElmer (PKI) to Acquire German Firm EUROIMMUN for $1.3B

        by Zacks Equity Research

        PerkinElmer Inc. (PKI) recently announced that it will acquire EUROIMMUN Medical Laboratory Diagnostics AG for approximately $1.3 billion in cash.

          PAREXEL Announces Acquisition by Pamplona Capital for $5B

          by Zacks Equity Research

          PAREXEL International Corporation (PRXL) recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP.

            Why Investors Should Retain Molina Healthcare (MOH) Stock

            by Zacks Equity Research

            Molina Healthcare, Inc. (MOH) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals.

              Teladoc (TDOC) to Raise Debt for Best Doctors Acquisition

              by Zacks Equity Research

              Teladoc, Inc. (TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022.

                Medidata Solutions (MDSO) Set to Join the S&P 400 Index

                by Zacks Equity Research

                Medidata Solutions Inc. (MDSO), a leading global provider of clinical development solutions, is scheduled to join the coveted S&P 400 benchmark before the opening bell on Jun 26.

                  Medtronic CRT Devices Improve Therapy Delivery, Cut Costs

                  by Zacks Equity Research

                  Medtronic plc (MDT) recently announced positive data on cardiac resynchronization therapy (CRT) devices within its Cardiac and Vascular segment.

                    Hologic (HOLX) Gets FDA Clearance for Aptima HSV 1 & 2 Test

                    by Zacks Equity Research

                    Hologic, Inc. (HOLX) recently received FDA approval for the commercial launch of the Aptima Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther system.

                      Genomic Health Cancer Tests Strong, Operating Expenses a Woe

                      by Zacks Equity Research

                      On Jun 19, we issued an updated research report on Redwood City, CA-based Genomic Health Inc (GHDX), a global cancer research company with a focus on advanced molecular diagnostics.

                        Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High

                        by Zacks Equity Research

                        Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.

                          Luminex (LMNX) Scores a Strong Buy Right Now: Here's How

                          by Zacks Equity Research

                          With solid growth prospects, Luminex Corporation (LMNX) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.

                            ResMed (RMD) at 52-Week High: What's Driving the Stock?

                            by Zacks Equity Research

                            Share price of ResMed Inc. (RMD) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91.

                              PRA Health (PRAH) Shares Rally on Partnership with Jumo

                              by Zacks Equity Research

                              Shares of PRA Health (PRAH) rallied 2.3% to close at $75.50, following PRA Health's recently announced partnership with Jumo, a global provider of educational health care information.

                                Neogen Offers NeoSeek Genomic Services to Ensure Food Safety

                                by Zacks Equity Research

                                Headquartered in Lansing, MI, Neogen Corporation (NEOG) recently announced the availability of next generation sequencing services for the food industry.

                                  PAREXEL to Launch Connected Journey Data-Driven Services

                                  by Zacks Equity Research

                                  PAREXEL International Corporation (PRXL) recently announced the launch of its proprietary data-driven services, Connected Journey.

                                    Medtronic Posts Positive Result on Reactive ATP, Grows in AF

                                    by Zacks Equity Research

                                    Medtronic's (MDT) Reactive ATP therapy slows the progression of AF in patients who are being implanted with cardiac devices.

                                      DENTSPLY (XRAY) Renews Partnership with Pacific Dental

                                      by Zacks Equity Research

                                      DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.

                                        Universal Health Grows on Acquisitions, Rising Debt a Drag

                                        by Zacks Equity Research

                                        Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.

                                          Inogen (INGN) Scores a Strong Buy Right Now: Here's How

                                          by Zacks Equity Research

                                          Goleta, CA-based Inogen Inc. (INGN), a provider of portable oxygen concentrators (POC), is on a healthy growth trajectory of late.

                                            Why Does Intuitive Surgical Score as a Strong Buy Right Now

                                            by Zacks Equity Research

                                            Over the last three months, Intuitive Surgical Inc. (ISRG) was trading consistently ahead of the S&P 500 Index.

                                              Pacific Biosciences (PACB) Prices Offering of Common Stock

                                              by Zacks Equity Research

                                              Pacific Biosciences of California, Inc. (PACB) recently announced that it has priced its underwritten public offering of 15.4 million shares of its common stock.

                                                DaVita (DVA) Rolls Out Alliance Site Network for CKD Trial

                                                by Zacks Equity Research

                                                DaVita Inc (DVA), through its subsidiary DaVita Clinical Research (DCR), recently announced the expansion of its research services to include Alliance Site Network.

                                                  Varian Showcases Halcyon System at DEGRO Meet, Stock Up

                                                  by Zacks Equity Research

                                                  Shares of Varian Medical Systems Inc. (VAR) rallied almost 1% after the company showcased a new Halcyon radiotherapy treatment system at the 2017 DEGRO meeting, the German radiation oncology society, in Berlin.